NASDAQ:RNTX | EBITDA | Rein Therapeutics, Inc.

Complete source-backed ebitda history.

Available history
2015-12-31 to 2025-12-31
Data captured

Historical EBITDA

DateEBITDA
2025-12-31-$32.66M
2025-03-31-$5.61M
2024-12-31-$42.8M
2024-03-31-$7.15M
2023-12-31-$7.24M
2023-03-31-$4.97M
2022-12-31-$4.66M
2022-03-31-$8.38M
2021-12-31-$6.78M
2021-03-31-$6.99M
2020-12-31-$4.18M
2020-03-31-$6.81M
2019-12-31-$7.27M
2019-03-31-$7.28M
2018-12-31-$6.93M
2018-03-31-$7.72M
2017-12-31-$7M
2017-03-31-$4.57M
2016-12-31-$4.41M

Annual EBITDA

DateEBITDA
2025-12-31-$50.63M
2024-12-31-$65.05M
2023-12-31-$16.16M
2022-12-31-$27.48M
2021-12-31-$26.48M
2020-12-31-$20.33M
2019-12-31-$29.8M
2018-12-31-$31.68M
2017-12-31-$22.88M
2016-12-31-$17.94M
2015-12-31-$12.57M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.